NeoStem To Present at Rodman & Renshaw Annual China Investment Conference on Tuesda... ( NEW YORK March 7 2011 /- NeoStem Inc....)

NeoStem To Present at Rodman & Renshaw Annual China Investment Conference on Tuesday, March 8

Date:3/7/2011

NEW YORK, March 7, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS), an international biopharmaceutical company with operations in the U.S. and China, announced today that Dr. Ian Zhang, PhD, MBA, President and Managing Director of NeoStem (China), Inc. will present at the Rodman & Renshaw Annual China Investment Conference on Tuesday, March 8, 2011. The Conference, which runs from March 6 – 8, 2011, is being held at Le Royal Meridien Shanghai, at 789 Nanjing Road East in Shanghai, China, and Dr. Zhang will speak from 11:30 to 11:55 AM Beijing Time in Parlour V.

Dr. Ian Zhang will discuss NeoStem's operations in China and development strategy going forward. In 2010, the Company began generating revenues from its stem cell-based regenerative medicine therapies, a key element of its growth strategy in both the United States and China. This effort began through a collaboration with Wendeng Hospital in China. Patients now have the opportunity to access the latest technology from the US in the treatment of a range of orthopedic conditions. Ongoing commercialization of NeoStem's licensed orthopedic applications at Wendeng Hospital is being facilitated by the local government's approval of pricing and reimbursement for these therapies. Patients are eligible for reimbursement of up to 80% of the cost of the procedure. NeoStem continues to expand its collaborations, recently adding Shijiazhuang Third Hospital in Hebei Province in December, 2010.

Dr. Ian Zhang said, "I look forward to meeting with the Chinese investment community and raising awareness regarding NeoStem's progress in China. Additionally, we are working closely with our newly acquired subsidiary, Progenitor Cell Therapy, LLC ("PCT"), an internationally recognized cell therapy services and development company that, through its cGMP certified manu
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. NeoStem to Launch New Service and Has Engaged Healthcare Personality Dr. Manny Alvarez to Serve as Spokesperson
2. NeoStem to Present at 13th Annual BIO CEO & Investor Conference
3. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
4. NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011
5. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
6. NeoStem to Present at Two Investor Conferences Thursday, November 18, 2010
7. NeoStem Announces Pricing of Concurrent Offerings for $19 Million in Gross Proceeds
8. NeoStem Provides Third Quarter Update
9. NeoStem to Present at LifeTech Capital Miami Medical Investors Conference
10. Local Chinese Government Authorities Approve Pricing and Reimbursement for NeoStems Licensed Adult Stem Cell Treatments for Orthopedic Applications in China
11. NeoStem to Present at Cell Therapy Industry Summit to be held on November 3-5, 2010 in Carlsbad, California

Post Your Comments:

(Date:5/21/2013)... , May 21, 2013 Decision Resources, ... advisory firms for pharmaceutical and healthcare issues, ... agent on key efficacy endpoints, including overall ... the most influence over surveyed U.S. and ... (HR-) positive, HER2-negative breast cancer. The two ...

(Date:5/21/2013)... NORTH BRUNSWICK, N.J. , May 21, 2013 /PRNewswire/ ... artificial tissue constructs and microfluidic cell-based assay platforms, today ... , PhD, DABT to the Company,s Board of ... of Preclinical Development of the Schering-Plough Research Institute ("SPRI"), ... prior to its acquisition by Merck & Co. in ...

(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Technologies for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES ... study is to offer synopsis of the ...

[0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors [0] Global Markets and Technologies for Optical Coherence Tomography (OCT)

... 19, 2011 Varian Medical Systems, Inc., ... Inc., today announced they have signed a definitive agreement ... developer and supplier of specialized products and software for ... radiotherapy. The acquisition, which is anticipated to close in ...

... Sept. 19, 2011 VIDA Diagnostics, a leading developer ... company has achieved International Organization for Standardization (ISO 13485) ... The CE certification permits VIDA to sell Apollo for ... Switzerland. Apollo currently has FDA 510(k) approval for clinical ...

Cached Medicine Technology:Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 2 Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 3 Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 4 Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 5

Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy VIDA Diagnostics Earns ISO 13485 and CE Certifications

(Date:5/21/2013)... (PRWEB) May 21, 2013 DISCcert has ... showing how to use 17 DISC applications at the ... a natural progression. , The July 25 & 26th ... top 17 ways of applying DISC. The time-tested, proven ... graduates. The user-friendly DISC training materials ; ...

(Date:5/21/2013)... 21, 2013) Prostaglandin analogues (PGAs), drugs which lower ... for people with glaucoma, but their use is not ... vision, dryness, changes in eye color and other side ... drugs also cause upper and lower eyelid drooping and ... are described in PLOS ONE . , Researchers ...

(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and ... free Community Wellness Fair to educate the public on health ... held on Wednesday, May 22, 2013 from 4:00 pm until ... Old Mallard Creek Road, Charlotte, NC 29262). , ... the Mecklenburg County Department of Social Services are ...

(Date:5/21/2013)... 2013, Paris, France: One-year results from SOURCE XT ... (TAVI) registries to-date reported today at EuroPCR 2013 ... high rates of device success for all access approaches, ... Post-Approval Study followed up 2688 consecutively enrolled patients (mean ... heart valve at 93 centres in 17 countries between ...

(Date:5/21/2013)... Angeles, CA (PRWEB) May 21, 2013 According ... “Time to Rethink the Use of Botox,” Botox ... world since their approval in 2002 (Go to goo.gl/8iYbD). Although ... become quite popular with men. The injection makes facial wrinkles ... single Botox injection last for about three months. This means ...

Breaking Medicine News(10 mins):Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4 Health News:Glaucoma drug can cause droopy eyelids 2 Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2 Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2

[0] DISCcert Offers 17 Applications in Coming DISC Certification [0] Glaucoma drug can cause droopy eyelids [0] Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives [0] Post-approval TAVI registry shows high rates of device success at 1 year [0] Botox – Is the World’s Most Popular Cosmetic Procedure Safe?

... Minority Quality Forum Launches First U.S. HIV/AIDS Atlas , ... today launched a groundbreaking HIV/AIDS Atlas ( http://www.MapHIV.org ... epidemic in communities across the United States. The Atlas ... location for the first time, painting a comprehensive picture of ...

... Perfect Time for Fitness! , , LOS ANGELES, June 22 ... in the park or along the beach. Now a brand new ... fitness equipment on wheels, but with a unique design to allow ... a new concept of fitness, will be introduced to California starting ...

... , DentaBurst(TM) delivers an on-the-go oral care solution to ... NEW YORK, June 22 Crown Consumer Brands today ... the original proven technology will remain intact, an improved, ... will accompany this highly anticipated re-launch. , ...

... MUSCLEPHARM(R) LLC, the rising star of the Sports Nutrition ... through each of Vitamin Shoppe,s 400+ locations nationwide. , ... launch of our entire line of products," MUSCLEPHARM president ... athletes in nearly every neighborhood across the nation! Vitamin ...

... Transcend Medical, Inc., an ophthalmic device company dedicated ... announced today that it has closed a $35 million ... of its Transcend CyPass(TM) System, a novel proprietary system ... Lead investor HLM Venture Partners, along with other new ...

... Magnetic Resonance Center of the University Children,s Hospital ... in MR-guided, non-invasive neurosurgery. Ten patients have been ... ultrasound. This fully non-invasive procedure opens new horizons ... brain disorders. In the context of a ...

Cached Medicine News:Health News:MapHIV.org Shows 18% of Georgia's Counties are Seriously Impacted by HIV 2 Health News:MapHIV.org Shows 18% of Georgia's Counties are Seriously Impacted by HIV 3 Health News:Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 2 Health News:Crown Consumer Brands Re-Launches DentaBurst(TM) Freshening Teeth Cleaners 2 Health News:MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang! 2 Health News:Transcend Medical Raises $35 Million Series B Round Towards Development of Novel Glaucoma Treatment 2 Health News:Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound 2 Health News:Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound 3

MapHIV.org Shows 18% of Georgia's Counties are Seriously Impacted by HIV Pumgo Fitness Scooter Will Highlight Venice Beach This Summer Crown Consumer Brands Re-Launches DentaBurst(TM) Freshening Teeth Cleaners MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang!Transcend Medical Raises $35 Million Series B Round Towards Development of Novel Glaucoma Treatment Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Reducing Substances, Fecal RBC Fecal Rapid Plasma Reagin (RPR with Reflex to Fluorescent Treponemal Antibody, IgG Confirmation Rabies Antibody(Vaccine Response)